These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2018044)
1. The challenge of combination antiretroviral therapy for AIDS. An introduction. Groopman JE Am J Med; 1991 Apr; 90(4A):1S. PubMed ID: 2018044 [No Abstract] [Full Text] [Related]
2. Treatment of AIDS with combinations of antiretroviral agents: a summary. Groopman JE Am J Med; 1991 Apr; 90(4A):27S-30S. PubMed ID: 2018049 [No Abstract] [Full Text] [Related]
3. [AIDS. Combination therapy is more favorable]. Fortschr Med; 1988 Sep; 106(28):57. PubMed ID: 3069665 [No Abstract] [Full Text] [Related]
4. A new HIV/AIDS drug. J Ark Med Soc; 1996 Jan; 92(8):407. PubMed ID: 8582889 [No Abstract] [Full Text] [Related]
5. [A new AIDS drug in evaluation]. Fortschr Med; 1993 Aug; 111(24):12. PubMed ID: 7691696 [No Abstract] [Full Text] [Related]
6. 3TC approval may revive AZT's appeal. Vazquez E Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136 [TBL] [Abstract][Full Text] [Related]
7. Study results at a glance. AIDS Alert; 1995 Nov; 10(11):134. PubMed ID: 11362922 [TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy for infection due to human immunodeficiency virus in children. Pizzo PA; Wilfert C Pediatr AIDS HIV Infect; 1994 Oct; 5(5):273-95. PubMed ID: 11361369 [No Abstract] [Full Text] [Related]
9. Treatment of CMV retinitis. Cox SW; Wahren B N Engl J Med; 1992 Jun; 326(25):1701-2; author reply 1702-3. PubMed ID: 1534145 [No Abstract] [Full Text] [Related]
10. [Present and future of the antiretroviral therapy]. Martinez-Vazquez JM; Cabarcos A An Med Interna; 1996 Jan; 13(1):1-3. PubMed ID: 8679816 [No Abstract] [Full Text] [Related]
12. Antiretroviral treatment: state of the art and future directions. Lange JM; Cooper DA; Danner SA AIDS; 1991; 5 Suppl 2():S181-8. PubMed ID: 1726955 [No Abstract] [Full Text] [Related]
13. Studies confirm value of early and combination treatments. Vazquez E Posit Aware; 1995; VI(6):8. PubMed ID: 11363148 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy with ZDV and interferon-alpha-2a promotes tumor regression. J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363699 [TBL] [Abstract][Full Text] [Related]
15. Outdated yet out-of-reach: AIDS society treatment guidelines at the International Conference. Torres G GMHC Treat Issues; 1996 Sep; 10(9):7, 10-1. PubMed ID: 11363842 [TBL] [Abstract][Full Text] [Related]
16. [Prospects in the treatment of AIDS. II. AZT and related compounds; practical conclusions]. Grieb P Pol Arch Med Wewn; 1992; 87(4-5):316-23. PubMed ID: 1381825 [No Abstract] [Full Text] [Related]
17. Making sense of 175 and Delta. Smart T GMHC Treat Issues; 1995 Oct; 9(10):4. PubMed ID: 11362916 [TBL] [Abstract][Full Text] [Related]
18. [What is the future of antiviral therapy of HIV-infected patients? Reports of results of antiretroviral therapy studies at the IX. World Congress on AIDS in Berlin]. Baumgarten R Z Arztl Fortbild (Jena); 1993 Dec; 87(12):925-6. PubMed ID: 8147004 [No Abstract] [Full Text] [Related]
19. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive. James JS AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363075 [TBL] [Abstract][Full Text] [Related]
20. Can the conundrums of ACTG 175 be solved? An interview with Martin S. Hirsch, MD. Hirsch MS J Int Assoc Physicians AIDS Care; 1995 Oct; 1(9):29-30. PubMed ID: 11362965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]